Zydus Cadila gets USFDA nod for thyroid drug

Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Liothyronine Sodium tablets USP, 5 mcg, 25 mcg, and 50 mcg, Cadila Healthcare said in a regulatory filing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3paJAVZ
via IFTTT